Jaime
Gállego Pérez de Larraya
Consultor Médico
Pitié-Salpêtrière Hospital
París, FranciaPublications in collaboration with researchers from Pitié-Salpêtrière Hospital (11)
2023
-
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53
2016
-
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma
Cancer Investigation, Vol. 34, Núm. 1, pp. 39-44
2015
-
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab
Journal of Neuro-Oncology, Vol. 121, Núm. 3, pp. 499-504
2014
-
An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomas
BioMed Research International, Vol. 2014
-
Brain metastases
Handbook of Clinical Neurology (Elsevier B.V.), pp. 1143-1157
-
Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma
Cancer, Vol. 120, Núm. 24, pp. 3972-3980
-
Management of elderly patients with gliomas
Oncologist, Vol. 19, Núm. 12, pp. 1258-1267
2012
-
Detection of IDH1 mutation in the plasma of patients with glioma
Neurology, Vol. 79, Núm. 16, pp. 1693-1698
-
Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia
Journal of Neuro-Oncology
2011
-
Erratum to: Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia (Journal of Neuro-Oncology DOI: 10.1007/s11060-011-0752- 9)
Journal of Neuro-Oncology
-
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: An ANOCEF phase II trial
Journal of Clinical Oncology, Vol. 29, Núm. 22, pp. 3050-3055